localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS.
Neuroscience 110:403– 420.
De Colle C, Bessis A-S, Bockaert J, Archer F, and Pin J-P (2000) Pharmacological
characterization of the rat metabotropic glutamate receptor type 8a revealed
strong similarities and slight differences with the type 4a receptor. Eur J Pharmacol 394:17–26.
Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D,
Sommer B, Varney MA, Hess SD, et al. (1999) (R,S)-4-phosphonophenylglycine, a
potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo. J Pharmacol Exp Ther 289:1678 –1687.
Ghauri M, Chapman AG, and Meldrum BS (1996) Convulsant and anticonvulsant
actions of agonists and antagonists of group III mGluRs. Neuroreport 7:1469 –
1474.
Han G and Hampson DR (1999) Ligand binding to the amino-terminal domain of the
mGluR4 subtype of metabotropic receptor. J Biol Chem 274:10008 –10013.
Jin X and Daw NW (1998) The group III metabotropic glutamate receptor agonist
L-AP4, reduces EPSPs in some layers of rat visual cortex. Brain Res 797:218 –
224.
Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S, and Schoepp DD (1998) LY341495 is a nanomolar potent and
selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37:1–12.
Knopfel T, Lukic S, Leonardt T, Flor PJ, Kuhn R, and Gasparini F (1995) Pharmacological characterization of MCCG and MAP4 at the mGluR1b, mGluR2 and
mGluR4a human metabotropic glutamate receptor subtypes. Neuropharmacology
34:1099 –1102.
Kosinski CM, Bradley SR, Conn PJ, Levey AI, Landwehrmeyer GB, Penney JB Jr,
Young AB, and Standaert DG (1999) Localization of metabotropic glutamate
receptor 7 mRNA and mGlu7a protein in the rat basal ganglia. J Comp Neurol
415:266 –284.
Lambe EK and Aghajanian GK (2001) The role of Kv1.2-containing potassium
channels in serotonin-induced glutamate release from thalamocortical terminals
in rat frontal cortex. J Neurosci 21:9955–9963.
Lambe EK and Aghajanian GK (2003) Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40:139 –150.
Lovinger DM and McCool BA (1995) Metabotropic glutamate receptor-mediated
presynaptic depression at corticostriatal synapses involves mGluR2 or 3. J Neurophysiol 73:1076 –1083.
Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, and Watson SJ (1994)
Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ
hybridization study. J Comp Neurol 350:412– 438.
Marek GJ and Aghajanian GK (1998) 5-HT-induced EPSCs in neocortical layer V
pyramidal cells: suppression by -opiate receptor activation. Neuroscience 86:485–
497.
Marek GJ and Aghajanian GK (1999) 5-HT2A or 1-adrenoceptor activation induces
excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal
cortex. Eur J Pharmacol 367:197–206.
Marek GJ, Carpenter LL, McDougle CJ, and Price LH (2003) Synergistic action of
5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 28:402– 412.
Marek GJ, Wright RA, Gewirtz JC, and Schoepp DD (2001) A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in neocortex.
Neuroscience 105:113–126.
Marek GJ, Wright RA, Schoepp DD, Monn JA, and Aghajanian GK (2000) Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic
glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292:76 – 87.
McCormick DA, Connors BW, Lighthall JW, and Prince DA (1985) Comparative
electrophysiology of pyramidal and sparsely spiny neurons of the neocortex. J Neurophysiol 54:782– 806.
Moghaddam B and Adams BW (1998) Reversal of phencyclidine effects by a group II
metabotropic glutamate receptor agonists in rats. Science (Wash DC) 281:1349 –
1352.
Muschamp JW, Regina MJ, Hull EM, Winter JC, and Rabin RA (2004) Lysergic acid
diethylamide and ( )-2,5-dimethoxy-4-methylamphetamine increase extracellular
glutamate in rat prefrontal cortex. Brain Res 1023:134 –140.
Naples MA and Hampson DR (2001) Pharmacological profiles of the metabotropic
glutamate receptor ligands [3H]L-AP4 and [3H]CPPG. Neuropharmacology 40:
170 –177.
Neto FL, Schadrack J, Berthele A, Zieglgansberger W, Tolle TR, and Castro-Lopes
JM (2000) Differential distribution of metabotropic glutamate receptor subtype
mRNAs in the thalamus of the rat. Brain Res 854:93–105.
Ohishi H, Akazawa C, Shigemoto R, Nakanishi S, and Mizuno N (1995) Distributions
of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain. J Comp Neurol 360:555–
570.
Ohishi H, Shigemoto R, Nakanishi S, and Mizuno N (1993) Distribution of the
messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central
nervous system of the rat. Neuroscience 53:1009 –1018.
Phillips T, Makoff A, Brown S, Rees S, and Emson P (1997) Localization of mGluR4
protein in the rat cerebral cortex and hippocampus. Neuroreport 8:3349 –3354.
Pisani A, Calabresi P, Centonze D, and Bernardi G (1997) Activation of group III
metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapses. Neuropharmacology 36:845– 851.
Saugstad JA, Kinzie JM, Shinohara MM, Segerson TP, and Westbrook GL (1997)
Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct
pharmacological profile. J Pharmacol Exp Ther 51:119 –125.
Schoepp DD, Jane DE, and Monn JA (1999) Pharmacological agents acting at
subtypes of metabotropic glutamate receptors. Neuropharmacology 38:1431–
1476.
